外泌体作为促炎介质在EBV相关淋巴瘤发生中的作用
研究探讨EBV通过外泌体分泌在肿瘤中反式作用于未感染巨噬细胞并促进淋巴瘤发生。人源化小鼠模型中两株EBV(Akata和B95-8)所致淋巴增殖性疾病(LPD)形成存在差异,注射Akata来源外泌体影响LPD严重程度。Akata淋巴母细胞系外泌体含BART miRNA和EBV编码RNA,BART miRNA可在体外诱导巨噬细胞免疫调节表型,EBV编码miRNA表达水平与老年弥漫大B细胞淋巴瘤患者临床结局密切相关。
要点
- EBV通过外泌体分泌在肿瘤中反式作用于未感染巨噬细胞,促进淋巴瘤发生。
- Akata与B95-8两株EBV在人源化小鼠中所致LPD形成存在明显差异。
- BART miRNA可诱导巨噬细胞免疫调节表型,或为EBV+ B细胞淋巴瘤诊断标志物。
核心结论
- BART miRNA可能是调节淋巴增殖性疾病严重程度的因素之一,并可作为EBV+ B细胞淋巴瘤的诊断标志物。
研究设计与样本
- 研究采用人源化小鼠模型,比较Akata和B95-8两株EBV所致淋巴增殖性疾病(LPD)形成的差异。
- 研究通过注射Akata来源外泌体观察其对LPD严重程度的影响,并体外研究BART miRNA对巨噬细胞表型的作用。
- 研究分析EBV编码miRNA表达水平与老年弥漫大B细胞淋巴瘤患者临床结局的关联。
主要发现
- 人源化小鼠模型中,Akata和B95-8两株EBV所致LPD形成存在明显差异。
- 注射Akata来源外泌体影响LPD严重程度,可能通过调节体内巨噬细胞表型实现。
- Akata淋巴母细胞系来源外泌体含BART miRNA和EBV编码RNA。
- 体外BART miRNA可诱导巨噬细胞免疫调节表型,表现为白细胞介素10、肿瘤坏死因子-α和精氨酸酶1基因表达。
- EBV编码miRNA表达水平与老年弥漫大B细胞淋巴瘤患者临床结局密切相关。
临床怎么用
- 作者认为BART miRNA可作为EBV+ B细胞淋巴瘤的诊断标志物。
- 作者认为BART miRNA是调节淋巴增殖性疾病严重程度的因素之一。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epstein-Barr virus (EBV) causes various diseases in the elderly, including B-cell lymphoma such as Hodgkin's lymphoma and diffuse large B-cell lymphoma. Here, we show that EBV acts in trans on noninfected macrophages in the tumor through exosome secretion and augments the development of lymphomas. In a humanized mouse model, the different formation of lymphoproliferative disease (LPD) between 2 EBV strains (Akata and B95-8) was evident. Furthermore, injection of Akata-derived exosomes affected LPD severity, possibly through the regulation of macrophage phenotype in vivo. Exosomes collected from Akata-lymphoblastoid cell lines reportedly contain EBV-derived noncoding RNAs such as BamHI fragment A rightward transcript (BART) micro-RNAs (miRNAs) and EBV-encoded RNA. We focused on the exosome-mediated delivery of BART miRNAs. In vitro, BART miRNAs could induce the immune regulatory phenotype in macrophages characterized by the gene expressions of interleukin 10, tumor necrosis factor-α, and arginase 1, suggesting the immune regulatory role of BART miRNAs. The expression level of an EBV-encoded miRNA was strongly linked to the clinical outcomes in elderly patients with diffuse large B-cell lymphoma. These results implicate BART miRNAs as 1 of the factors regulating the severity of lymphoproliferative disease and as a diagnostic marker for EBV+ B-cell lymphoma.
引用
- Higuchi H, Yamakawa N, Imadome KI, et al. Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma. Blood. 2018. PMID: 29685921. doi:10.1182/blood-2017-07-794529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。